THI OBI
LIVE

Serial Number

98424308

Owner

OBI PHARMA, INC.

Attorney

Ran He

Filing Date

Feb 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

THI OBI Trademark

Serial Number: 98424308 • Registration: 8182708

THI OBI is a trademark filed by OBI PHARMA, INC. on February 27, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

OBI PHARMA, INC.

Nangang Dist.
Taipei City 115011 , TW

Entity Type: 03

Trademark Details

Filing Date

February 27, 2024

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agents

Carbide; Cellulose; Glycogen; Glycoprotein; Sulfides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Adjuvants, other than for medical or veterinary purposes; Antioxidants for use in the manufacture of pharmaceuticals; Biochemical catalysts; Biological preparations for use in industry and science; Carbonic hydrates; Chemical additives for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Fatty acids for use in pharmaceutical; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Protein in raw material form for scientific and medical research; Proteins for use in manufacture; Proteins for use in the manufacture of drugs

Biological research; Biological research and analysis; Chemical analysis; Chemical research; Chemical research and analysis; Chemical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Providing information about medical research in the field of cancer, oncology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies

Administering vaccines to patients; Alternative medicine services; Cancer screening services; Cultured cell bank services for medical transplantation; Health care; Health care services for treating cancer; Health assessment services; Health counselling; Human tissue bank services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance; Medical screening; Medical treatment using cultured cells; Nursing, medical; Occupational therapy; Providing health information in the field of cancer prevention and treatment; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Regenerative medicine services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
CASE RETURNED TO EXAMINATION
Oct 27, 2025 OTHE
NOTICE OF ALLOWANCE CANCELLED
Oct 27, 2025 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Oct 27, 2025 PCBG
ASSIGNED TO PETITION STAFF
Oct 22, 2025 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Sep 22, 2025 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 17, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 16, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 27, 2024 CNEA
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 4, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2024 NWOS
NEW APPLICATION ENTERED
Mar 1, 2024 NWAP